Free Trial
TSE:APS

Aptose Biosciences (APS) Stock Price, News & Analysis

Aptose Biosciences logo
C$1.71 +0.01 (+0.59%)
As of 08/8/2025 03:59 PM Eastern

About Aptose Biosciences Stock (TSE:APS)

Key Stats

Today's Range
C$1.71
C$1.79
50-Day Range
C$1.09
C$2.50
52-Week Range
C$1.02
C$23.10
Volume
807 shs
Average Volume
5,450 shs
Market Capitalization
C$73.63 million
P/E Ratio
N/A
Dividend Yield
0.39%
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Receive APS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aptose Biosciences and its competitors with MarketBeat's FREE daily newsletter.

APS Stock News Headlines

Aptose Biosciences Inc. (APS.TO) - Yahoo Finance
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
Aptose Biosciences, Inc.: Aptose Provides Corporate Updates
Aptose Biosciences shares to delist from Nasdaq as of April 2
See More Headlines

APS Stock Analysis - Frequently Asked Questions

Aptose Biosciences' stock was trading at C$9.75 at the beginning of 2025. Since then, APS stock has decreased by 82.5% and is now trading at C$1.71.

Shares of Aptose Biosciences reverse split on Wednesday, February 26th 2025.The 1-30 reverse split was announced on Wednesday, February 26th 2025. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, February 26th 2025. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Shares of APS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aptose Biosciences investors own include Aptose Biosciences (APTO), Aurinia Pharmaceuticals (AUPH), NVIDIA (NVDA), Advanced Micro Devices (AMD), VistaGen Therapeutics (VTGN), BlackBerry (BB) and Micron Technology (MU).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:APS
CIK
N/A
Fax
N/A
Employees
31
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($5.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$154.69 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
1,017.48%
Return on Assets
-136.29%

Debt

Debt-to-Equity Ratio
-117.37
Current Ratio
1.05
Quick Ratio
5.41

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$1.07 per share
Price / Cash Flow
1.60
Book Value
C($0.92) per share
Price / Book
-1.87

Miscellaneous

Outstanding Shares
43,058,192
Free Float
N/A
Market Cap
C$73.63 million
Optionable
Not Optionable
Beta
1.36
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (TSE:APS) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners